Literature DB >> 7470741

Uptake of radiocalcium by nerve endings isolated from rat brain: kinetic studies.

J Gripenberg, E Heinonen, S E Jansson.   

Abstract

1 The uptake of radiocalcium by nerve-ending particles isolated from rat brain was studied in vitro by means of a rapid lanthanum quenching technique. 2 The observed uptake fits a theoretical three-compartment model with two separate uptake phases, a fast, initial phase followed by a late, slow phase. This holds true during control conditions as well as during high-potassium stimulation. 3 The uptake as a function of the external calcium concentration can be described in terms of Michaelis-Menten kinetics during high-potassium stimulation. Under control conditions the fit is clearly applicable but statistically not as good as during potassium stimulation. 4 The affinity for the uptake of calcium remains unchanged under control conditions while during high-potassium stimulation the affinity drastically decreases during the late, slow phase of uptake. 5 During high-potassium stimulation the maximal velocity of calcium uptake is twice that during control conditions. This holds true for both the fast and the slow phases of the uptake. 6 Mg2+ has an inhibitory effect on the uptake, the inhibition being more effective during high-potassium stimulation. Tetrodotoxin has a slight inhibitory effect additional to that extended by Mg2+ during the initial phase of uptake into high potassium stimulated synaptosomes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7470741      PMCID: PMC2044414          DOI: 10.1111/j.1476-5381.1980.tb10935.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  An improved scintillation cocktail of high-solubilizing power.

Authors:  L E Anderson; W O McClure
Journal:  Anal Biochem       Date:  1973-01       Impact factor: 3.365

2.  Further study of the role of calcium in synaptic transmission.

Authors:  B Katz; R Miledi
Journal:  J Physiol       Date:  1970-05       Impact factor: 5.182

3.  Transmitter release induced by injection of calcium ions into nerve terminals.

Authors:  R Miledi
Journal:  Proc R Soc Lond B Biol Sci       Date:  1973-07-03

4.  Factors controlling cytoplasmic Ca 2+ concentration.

Authors:  C van Breemen; B R Farinas; R Casteels; P Gerba; F Wuytack; R Deth
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1973-03-15       Impact factor: 6.237

5.  Calcium role in depolarization-secretion coupling: an aequorin study in squid giant synapse.

Authors:  R Llinás; C Nicholson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

6.  Co-operative action a calcium ions in transmitter release at the neuromuscular junction.

Authors:  F A Dodge; R Rahamimoff
Journal:  J Physiol       Date:  1967-11       Impact factor: 5.182

7.  Calcium entry in response to maintained depolarization of squid axons.

Authors:  P F Baker; H Meves; E B Ridgway
Journal:  J Physiol       Date:  1973-06       Impact factor: 5.182

8.  Depolarization and calcium entry in squid giant axons.

Authors:  P F Baker; A L Hodgkin; E B Ridgway
Journal:  J Physiol       Date:  1971-11       Impact factor: 5.182

9.  Tetrodotoxin-resistant electric activity in presynaptic terminals.

Authors:  B Katz; R Miledi
Journal:  J Physiol       Date:  1969-08       Impact factor: 5.182

10.  A study of synaptic transmission in the absence of nerve impulses.

Authors:  B Katz; R Miledi
Journal:  J Physiol       Date:  1967-09       Impact factor: 5.182

View more
  2 in total

Review 1.  Effects of chronic neuroleptic treatment on dopamine release: insights from studies using 3-methoxytyramine.

Authors:  M F Egan; S Chrapusta; F Karoum; B K Lipska; R J Wyatt
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

2.  Uptake of radiocalcium by nerve endings isolated from rat brain: pharmacological studies.

Authors:  J Gripenberg; E Heinonen; S E Jansson
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.